Institutional Ownership of SYRE
Institutional investors managing over $100M must disclose their holdings to the SEC each quarter through Form 13F filings. Below are the most recently reported SYRE positions in Spyre Therapeutics, Inc., with each institution’s change versus its previous quarterly filing.
Institutions (recent filings)
—
Reported Shares
—
Reported Value
—
Adding vs Reducing
—
SYRE Stock Institutional Owners
Common-share positions from the latest 13F filings, newest first
| Investor | Shares | Change in Shares | Market Value | Date Reported |
|---|---|---|---|---|
| Scanning latest 13F filings on SEC EDGAR… | ||||
SYRE Derivatives Institutional Owners
PUT / CALL option positions on SYRE reported in the same filings
| Investor | Type | Underlying Shares | Market Value | Date Reported |
|---|---|---|---|---|
| Loading… | ||||
Source: SEC EDGAR Form 13F filings. Only institutions that filed within the last ~4 months appear here; positions reflect each filer’s most recent quarterly disclosure.